Chinese Journal of New Drugs Impact Factor in Pharmaceutics Journals

Chinese Journal of New Drugs in Pharmaceutics Journals

Journal Country: China
Journal Q tier: Q4
Publishing Firm: Chinese Journal of New Drugs Co. Ltd.
History: 2008-2022
Journal Homepage: ----
Journal ISSN: 10033734

Research Categories

Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)

Impact Score: 0.14
h-Index: 12
SJR: 0.112
Ranking: 25012

About Chinese Journal of New Drugs

Chinese Journal of New Drugs is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by Chinese Journal of New Drugs Co. Ltd.. The overall rank of Chinese Journal of New Drugs is 25012.According to SCImago Journal Rank (SJR), this journal is ranked 0.112. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 12. The best quartile for this journal is Q4.The ISSN of Chinese Journal of New Drugs journal is 10033734.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Chinese Journal of New Drugs is cited by a total of 198 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.